Matches in Nanopublications for { ?s ?p "[We retrospectively evaluated the efficacy and safety of high-dose erlotinib in EGFR-mutant non-small cell lung cancer (NSCLC) patients with refractory LM after failure of standard-dose EGFR-TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_assertion description "[We retrospectively evaluated the efficacy and safety of high-dose erlotinib in EGFR-mutant non-small cell lung cancer (NSCLC) patients with refractory LM after failure of standard-dose EGFR-TKIs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1281110.RAbiw71LwldIQITqgCZhDqafKWvUY3J3UDRzYMOEe46IU130_provenance.